| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,023 | 767 | 933 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 1,023 | 767 | 933 | | | Operating Expenses | | Research Development | 29,036 | 41,569 | 10,481 | | Selling General and Administrative | 9,134 | 7,399 | 3,523 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (37,147) | (48,201) | (13,071) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,562 | 2,062 | 1,169 | | Earnings Before Interest And Taxes | (35,585) | (46,139) | (11,902) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (35,585) | (46,139) | (11,902) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (35,585) | (46,139) | (11,902) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (35,585) | (46,139) | (11,902) | | Preferred Stock And Other Adjustments |
-
|
-
| (329) | | | Net Income Applicable To Common Shares | ($35,585) | ($46,139) | ($12,231) |
|
0.29% Nasdaq 
0.14 (1.21%) 
Income Statement
